ACE2 and AT4R are present in diseased human blood vessels

European Journal of Histochemistry

Volumn 52, Issue 1, 2008, Pages 39-44

  Zulli, Anthony ^a,b   Burrell, L M ^a   Buxton, B F ^b   Hare, D L ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

ACE2; AT4 receptors; Human blood vessels; IRAP

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 4 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II [3-8]; ANGIOTENSIN[1-7]; UNCLASSIFIED DRUG; ACTIN; ANGIOTENSIN RECEPTOR; AT4 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; INTERNAL MAMMARY ARTERY; INTIMA; PROTEIN LOCALIZATION; RADIAL ARTERY; SMOOTH MUSCLE FIBER; TUNICA MEDIA; VASA VASORUM; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; CHEMISTRY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CYTOLOGY; ENZYMOLOGY; MAMMARY ARTERY; METABOLISM; VASCULAR SMOOTH MUSCLE;

ACTINS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; MAMMARY ARTERIES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PEPTIDYL-DIPEPTIDASE A; RADIAL ARTERY; RECEPTORS, ANGIOTENSIN;

EID: 48249151833     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/1184     Document Type: Article

References (31)

1. Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, et al. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 2001;276: 48623-48626 (Pubitemid 37370555)
2. Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol 1995;269:H313-9.
3. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996;27:523-528
4. Burrell LM, Risvanis J, Kubota E, Dean RG, MacDonald PS, Lu S, et al. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J 2005;26:369-375; discussion 322-364 (Pubitemid 40283096)
5. Carey RM, Siragy HM Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 2003;24:261-271 (Pubitemid 36733542)
6. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002;417:822-828 (Pubitemid 34670323)
7. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000;52:415-472
8. Deddish PA, Marcic B, Jackman HL,Wang HZ, Skidgel RA, Erdos EG. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE. Hypertension 1998;31:912-917 (Pubitemid 28185567)
9. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000;87:E1-9.
10. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counterregulatory actions of angiotensin-(1-7). Hypertension 1997;30:535-541
11. Ferrario CM. Angiotension-(1-7) and antihypertensive mechanisms. J Nephrol 1998;11:278-283
12. Freeman EJ, Chisolm GM, Ferrario CM,Tallant EA. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996;28:104-108
13. Haberl RL, Decker PJ, Einhaupl KM. Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ Res 1991;68:1621-1627
14. Hall KL, Hanesworth JM, Ball AE, Felgenhauer GP, Hosick HL, Harding JW. Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV. Regul Pept 1993;44:225-232
15. Hall KL, Venkateswaran S, Hanesworth JM, Schelling ME, Harding JW. Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regul Pept 1995;58:107-115
16. Moeller I, Clune EF, Fennessy PA, Bingley JA, Albiston AL, Mendelsohn FA, et al. Up regulation of AT4 receptor levels in carotid arteries following balloon injury. Regul Pept 1999;83:25-30. (Pubitemid 29378362)
17. Nakamoto H, Ferrario CM, Fuller SB, Robaczewski DL,Winicov E, Dean RH. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension 1995;25:796-802.
18. Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, Smith AI, et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005;54:1790-1796 (Pubitemid 41697680)
19. Patel JM, Martens JR, Li YD, Gelband CH, Raizada MK, Block ER. Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation. Am J Physiol 1998;275:L1061-8. (Pubitemid 128734363)
20. Porsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol 1994;111:652-654
21. Roks AJ, van Geel PP, Pinto YM, Buikema H, Henning RH, de Zeeuw D, et al. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension 1999;34:296-301.
22. Ruengsakulrach P, Sinclair R, Komeda M, Raman J, Gordon I, Buxton B. Comparative histopathology of radial artery versus internal thoracic artery and risk factors for development of intimal hyperplasia and atherosclerosis. Circulation 1999;100:39-44. (Pubitemid 29523524)
23. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003;100:8258-8263
24. Swanson GN, Hanesworth JM, Sardinia MF, Coleman JK, Wright JW, Hall KL, et al. Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul Pept 1992;40:409-419
25. Tikellis C, Johnston CI, Forbes JM, Burns WC, Burrell LM, Risvanis J, et al. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003;41:392-397 (Pubitemid 36314606)
26. Wang L, Eberhard M, Erne P. Stimulation of DNA and RNA synthesis in cultured rabbit cardiac fibroblasts by angiotensin IV. Clin Sci (Lond) 1995;88:557-562
27. Wright JW, Krebs LT, Stobb JW, Harding JW. The angiotensin IV system: functional implications. Front Neuroendocrinol 1995;16:23-52.
28. Zulli A, Buxton BF, Black MJ, Hare DL. CD34 Class III positive cells are present in atherosclerotic plaques of the rabbit model of atherosclerosis. Histochem Cell Biol 2005;124:517-522 (Pubitemid 41661367)
29. Zulli A, Burrell LM, Widdop RE, Black MJ, Buxton BF, Hare DL. Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques. J Histochem Cytochem 2006a;54:147-150 (Pubitemid 43201635)
30. Zulli A, Buxton BF, Black MJ, Ming Z, Cameron A, Hare DL. The immunoquantification of caveolin-1 and eNOS in human and rabbit diseased blood vessels. J Histochem Cytochem 2006b;54:151-159 (Pubitemid 43201636)
31. Zulli A, Buxton BF, Black MJ, Hare DL. Embryonic stem cells markers are present within rabbit atherosclerotic plaques. Histol Histopathol 20077 in press. (Pubitemid 351552359)